# Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)

> **NCT00396110** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 3889 (—)

## Conditions studied

- Hypercholesterolemia
- Coronary Heart Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00396110
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 3889 (—)
- **Last updated:** 2006-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396110, "Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00396110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*